Abstract
Normal cardiac function relies on the actions of circulatory mechanisms and controls. In this chapter, circulatory physiology is examined with the aim of elucidating models of heart failure, pinpointing targets of therapy, and identifying neurohormonal mediators of the progression of heart failure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Grossman W. Cardiac catheterization and angiography. 5 ed. Baltimore: Williams and Wilkins, 1996; 281–295.
Somlyo AP, Somlyo AV. Smooth muscle structure and function. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, editors. The heart and cardiovascular system. 2 ed. New York: Raven, 1992; 1295–1324.
Peterson KL, Skloven D, Ludbrook P, Uther JB, Ross JJ. Comparison of isovolumic and ejection phase indices of myocardial performance in man. Circulation. 1974; 49:1088–1101.
Ross JJ. Applications and limitations of end-systolic measures of ventricular performance. Fed.Proc. 1984; 43:2418–2422.
Wroblewski H, Norgaard T, Haunso S, Kastrup J. Microvascular distensibility in two different vascular beds in idiopathic dilated cardiomyopathy. Am.J.Physiol. 1995; 269:H1973–H1980.
Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J.Clin.Invest. 1985; 75:643–649.
Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N.Engl.J.Med. 1984; 311:819–823.
Cohn JN, Levine TB, Francis GS, Goldsmith S. Neurohumoral control mechanisms in congestive heart failure. Am.Heart J. 1981; 102:509–514.
Daly PA, Sole MJ. Myocardial catecholamines and the pathophysiology of heart failure. Circulation. 1990; 82:l35–l43.
Colucci WS, Denniss AR, Leatherman GF, Quigg RJ, Ludmer PL, Marsh JD, et al. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition. J.Clin.Invest. 1988; 81:1103–1110.
Levine TB, Francis GS, Goldsmith SR, Cohn JN. The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation. 1983; 67:1070–1075.
Ferguson DW, Abboud FM, Mark AL. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation. 1984; 69:451–460.
Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan EDJ. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N.Engl.J.Med. 1987; 316:793–797.
Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981; 63:645–651.
Hirsch AT, Pinto YM, Schunkert H, Dzau VJ. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am.J.Cardiol. 1990; 66:22D–30D.
Delcayre C, Silvestre J. Aldosterone and the heart: towards a physiological function? Cardiovasc.Res. 1999; 43:7–12.
MacFadyen RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc.Res. 1997; 35:30–34.
Wang W, McClain JM, Zucker IH. Aldosterone reduces baroreceptor discharge in the dog. Hypertension. 1992; 19:270–277.
Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990; 82:1730–1736.
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N.Engl.J.Med. 1999; 341:709–717.
Dzau VJ. Tissue renin-angiotensin system: physiologic and pharmacologic implications. Introduction. Circulation. 1988; 77:I1–I3.
Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system. J.Hypertens. 1984; 2:581–587.
Riegger GA, Kochsiek K. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. Am.J.Cardiol. 1986; 58:300–303.
Zisman LS. Inhibiting tissue angiotensin-converting enzyme: a pound of flesh without the blood? Circulation. 1998; 98:2788–2790.
Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J.Am.Coll.Cardiol. 1992; 20:248–254.
Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N.Engl.J.Med. 1991; 325:1468–1475.
Dies F, Krell M.J., Whitlow P, Liang C, Goldenberg I, Applefeld M, et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation. 1998; Abstract.
Packer M, Rouleau JL, Swedberg K, Pitt B, Fisher L, Klepper M. Effect of Flosequinan on survival in chronic heart failure: preliminary results of the PROFILE study. Circulation. 1993; 88 (Supp I):I-301 Abstract.
Katz AM. Heart Failure. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, editors. The heart and cardiovascular system. 2 ed. New York: Raven, 1992; 333–353.
Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N.Engl.J.Med. 1996; 334:809–814.
Cohn JN. Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III. Drugs 1994; 47 (Suppl 4):47–57; discussion 57–8:47–57.
Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990; 82:1724–1729.
Tsuchimochi H, Kurimoto F, Leki K, Koyama H, Takaku F, Kawana M, Kimata S, Yazaki Y. Atrial natriuretic peptide distribution in fetal and failed adult human hearts. Circulation. 1988; 78:920–927.
McMullen ET. Anatomy of a physiological discovery: William Harvey and the circulation of the blood. J.R.Soc.Med. 1995; 88:491–498.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jaski, B.E. (2000). Circulation. In: Basics of Heart Failure. Developments in Cardiovascular Medicine, vol 228. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4379-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4379-4_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6969-1
Online ISBN: 978-1-4615-4379-4
eBook Packages: Springer Book Archive